NCT02614794 · Interventional trial
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Overall registry status Completed
Phase 2
Conditions HER2 Positive Breast Cancer
Delaware Valley sites
- Cancer Treatment Centers of America / Eastern Regional Medical Center · Philadelphia, PA · Philadelphia County
- University of Pennsylvania / Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory